← Evidence map

ArticleFrontiers in oncology2021

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.

Zhenjun Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34660326